Responsum Health Revenue and Competitors

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • Responsum Health's estimated annual revenue is currently $1.9M per year.(i)
  • Responsum Health's estimated revenue per employee is $162,000

Employee Data

  • Responsum Health has 12 Employees.(i)
  • Responsum Health grew their employee count by -20% last year.

Responsum Health's People

NameTitleEmail/Phone
1
Chief Content EditorReveal Email/Phone
2
VP OperationsReveal Email/Phone
3
VP, Strategic Partnerships & ImpactReveal Email/Phone
4
Director Community RelationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$44.8M15115%N/AN/A
#2
$79.3M2676%N/AN/A
#3
$3.1M19-14%N/AN/A
#4
$7.8M3644%N/AN/A
#5
$2.9M186%N/AN/A
#6
$6.5M307%N/AN/A
#7
$71.3M24018%N/AN/A
#8
$8.4M398%N/AN/A
#9
$10.2M474%N/AN/A
#10
$12.6M524%N/AN/A
Add Company

What Is Responsum Health?

Developed from years of research, interviews, and collaboration with patients from across the globe, Responsum Health's disease-specific apps are designed to improve patients' knowledge, grow their self-confidence, and provide for the organization and coordination of their health care information. Today, thousands of patients with pulmonary fibrosis and their caregivers rely on Responsum Health's app and content for their daily information. In the coming weeks and months, we will be announcing the launch of new apps for use by patients with other health conditions.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$1.9M

Revenue (est)

-20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Responsum Health News

2022-03-22 - Health Beat: Injectrode to better treat neurodegenerative ...

(Ivanhoe Newswire)— Neuromodulation therapies involve medical devices that can treat several chronic conditions, such as epilepsy, essential tremors,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M12N/AN/A
#2
$7.5M129%N/A
#3
$1.6M12-8%N/A
#4
$0.9M120%N/A
#5
$1.9M120%N/A